The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Firm Fixed Price delivery order contract to Biofire Defense LLC, a for-profit limited liability company manufacturer, to provide an Operational BWA IVD Assay Delivery. The contract has a potential value of $997,844.10 and a completion date of October 20, 2023. This award is part of a larger indefinite delivery contract that Biofire Defense holds with the Army's Chemical and Biological...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for research and development on a topic related to chemical/biological defense. The firm-fixed-price contract, with a potential value of $149,756.40, was awarded on October 1, 2018 and is scheduled for completion by March 31, 2019. This SBIR Phase I contract is set...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a $1,699,940.85 definitive contract to Bio1 Systems, Inc. doing business as Bio1 Systems under a Small Business Innovative Research Program Phase II action. The firm fixed price contract is for ML Model Development services and will be performed in San Carlos, California over a 24 month period ending September 2024. The contract is set aside for total small business and...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a $889,385 firm fixed price delivery order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide OPERATIONAL BWA IVD ASSAY WARRIOR products and services from August 31, 2021 through October 28, 2021 in support of the agency's chemical and biological defense programs. No set aside designation or subcontractors were identified. Biofire Defense...
This is a $82,499.02 firm fixed-price contract awarded by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), a defense agency, to Brhms LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I award under Topic #CBD181-007. SBIR Phase I awards fund the exploration of the technical merit or feasibility of an idea or technology. The contract has a completion date of April 14, 2019. This contract is a standalone award...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Firm Fixed Price delivery order to Biofire Defense LLC, a limited liability company and manufacturer, for the delivery of an Operational BWA IVD Assay. The award, which has a potential value of $460,163.46, was made on August 31, 2021 with a completion date of October 28, 2021. This delivery order is part of a larger indefinite delivery contract awarded to Biofire Defense in September 2023...
<p>This contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Evrys Bio LLC, a small disadvantaged business, woman-owned small business, and limited liability company. The contract is for an STTR (Small Business Technology Transfer) Phase I research project, with a firm fixed price of $149,997.49 and a completion date of December 31, 2019. The contract was set aside for small businesses.</p>
<p>This contract was awarded by the Department of the Army Medical Command to Bio1 Systems, Inc., a woman-owned small business, for a SBIR Program Phase I research effort. The contract was awarded on August 15, 2017 with a firm fixed price of $150,000.00 and a completion date of March 14, 2018. The contract was set aside for small businesses.</p>
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $160,501 firm fixed price definitive contract to Sio2 Medical Products Inc. of Auburn, AL on May 3, 2021. This Small Business Innovation Research (SBIR) Program Phase I action has a total small business set aside designation and requires completion of the research by November 2, 2021. The contract will support Sio2 Medical Products' Phase I proposal under the SBIR program to develop...
This is a $350,000.00 Other Transaction Agreement (OTA) awarded by the Defense Health Agency (DHA) to Aravo Solutions, Inc. for the development of a prototype contractor risk management tool. The contract has no set-aside designation and is scheduled for completion on December 19, 2025. As an OTA, this contract is not a traditional federal procurement contract and may involve more flexible terms and conditions compared to standard Federal Acquisition Regulation (FAR)-based contracts. The award...